Lynch Wendy J
Department of Psychiatric Medicine, University of Virginia Health System, Charlottesville, VA 22908, USA.
Exp Clin Psychopharmacol. 2006 Feb;14(1):34-41. doi: 10.1037/1064-1297.14.1.34.
Recent evidence from both human and animal studies indicates that there are sex differences in all phases of the addiction process, including initiation and acquisition of use, patterns and levels of use, the progression to addiction, and relapse. This brief review summarizes a series of studies on sex differences in drug self-administration in rats on which the Wyeth Young Psychopharmacologist Award was based and relates these findings to human clinical data. Briefly, preclinical findings show that female rats acquire drug self-administration at a faster rate, work harder to obtain drug infusions, "binge" for longer initial periods of time and show a more diurnally dysregulated pattern of self-administration under extended-access conditions, and respond at higher levels under reinstatement testing conditions compared with male rats. Similar results have been reported in humans, suggesting a biological basis of sex differences in vulnerability to drug abuse. A number of biological mechanisms have been explored, and the results show that ovarian hormones play a critical role in modulating the reinforcing effects of drugs of abuse in females. Preclinical studies, in conjunction with human studies, should further inform a sex-specific model for differences in drug abuse, and such a model may be useful for developing prevention and treatment strategies for drug abuse.
近期来自人体和动物研究的证据表明,成瘾过程的各个阶段都存在性别差异,包括使用行为的起始和习得、使用模式和程度、成瘾进展以及复吸。本简要综述总结了一系列关于大鼠药物自我给药性别差异的研究,惠氏青年精神药理学家奖就是基于这些研究设立的,并将这些发现与人类临床数据相关联。简而言之,临床前研究结果表明,与雄性大鼠相比,雌性大鼠获取药物自我给药的速度更快,为获得药物注射会更加努力,在较长的初始时间段内“暴饮暴食”,并且在延长获取条件下表现出更昼夜失调的自我给药模式,在复吸测试条件下反应水平更高。人类研究也报告了类似结果,这表明在药物滥用易感性方面性别差异存在生物学基础。已经探索了多种生物学机制,结果表明卵巢激素在调节雌性动物滥用药物的强化作用中起关键作用。临床前研究与人体研究相结合,应该能进一步为药物滥用差异的性别特异性模型提供信息,这样的模型可能有助于制定药物滥用的预防和治疗策略。